Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Dry powder inhaler is a medical device that is used for the effective delivery of medication to the lungs. The medication comes in the form of dry powder. The patients who suffer from various respiratory diseases make use of the dry powder inhalers as they are portable and are easy to carry.
The Dry Powder Inhaler Devices market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Dry Powder Inhaler Devices market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Dry Powder Inhaler Devices market.
Major Players in the Dry Powder Inhaler Devices market are:
GlaxoSmithKline Plc.
SRS Pharmaceuticals Pvt. Ltd
Teicos Pharma Ltd.
Cipla Inc.
Hovione FarmaCiencia SA.
Bespak Europe Ltd.
Catalent, Inc.
Presspart Manufacturing Ltd.
Luckys Pharma
AstraZeneca Plc.
Beximco Pharma Ltd.
On the basis of types, the Dry Powder Inhaler Devices market is primarily split into:
Single dose inhalers
Multi-dose inhalers
On the basis of applications, the market covers:
Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Others
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
2021
The Dry Powder Inhaler Devices market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Dry Powder Inhaler Devices market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Dry Powder Inhaler Devices market.
Major Players in the Dry Powder Inhaler Devices market are:
GlaxoSmithKline Plc.
SRS Pharmaceuticals Pvt. Ltd
Teicos Pharma Ltd.
Cipla Inc.
Hovione FarmaCiencia SA.
Bespak Europe Ltd.
Catalent, Inc.
Presspart Manufacturing Ltd.
Luckys Pharma
AstraZeneca Plc.
Beximco Pharma Ltd.
On the basis of types, the Dry Powder Inhaler Devices market is primarily split into:
Single dose inhalers
Multi-dose inhalers
On the basis of applications, the market covers:
Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Others
Major Region
s or countries covered in this report:United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years:
2017-2021Base Year:
2021Estimated Year:
2022Forecast Period:
2022-2029Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
